Detalhe da pesquisa
1.
Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort study.
J Am Acad Dermatol
; 90(4): 739-748, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38043594
2.
Sentinel lymph node biopsy for lentigo maligna melanoma under local anaesthesia.
J Eur Acad Dermatol Venereol
; 38(1): 84-92, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37611257
3.
Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients.
J Eur Acad Dermatol Venereol
; 38(4): 741-751, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38168748
4.
European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European Association of Dermato-Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes).
J Eur Acad Dermatol Venereol
; 38(6): 1024-1047, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38451047
5.
Tumescent local anesthesia in geriatric patients with head and neck skin cancer - a retrospective study of 782 patients.
J Dtsch Dermatol Ges
; 22(2): 210-221, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38243888
6.
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.
Lancet
; 400(10358): 1117-1129, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36099927
7.
The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st-3rd, 2022.
J Transl Med
; 21(1): 265, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37072748
8.
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy).
J Transl Med
; 21(1): 508, 2023 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37507765
9.
COLUMBUS 5-year update: a randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF.
Future Oncol
; 19(16): 1091-1098, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37309702
10.
Proteogenomics Reveals Perturbed Signaling Networks in Malignant Melanoma Cells Resistant to BRAF Inhibition.
Mol Cell Proteomics
; 20: 100163, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34673281
11.
Risk analysis of systemic side effects of tumescent local anaesthesia in the surgical treatment of geriatric and multimorbid patients with skin cancer.
J Eur Acad Dermatol Venereol
; 37(1): 65-74, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152007
12.
S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.
J Dtsch Dermatol Ges
; 21(11): 1422-1433, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840404
13.
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.
N Engl J Med
; 381(7): 626-636, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31166680
14.
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy).
J Transl Med
; 20(1): 391, 2022 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36058945
15.
Real-world Treatment Patterns and Outcomes with Systemic Therapies in Unresectable Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma in Germany.
Acta Derm Venereol
; 102: adv00637, 2022 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34842930
16.
The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review.
Radiol Med
; 127(7): 773-783, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35606609
17.
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 395(10236): 1558-1568, 2020 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32416781
18.
Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors.
Cancer Immunol Immunother
; 70(4): 1089-1099, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113003
19.
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy).
J Transl Med
; 19(1): 278, 2021 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34193182
20.
Expression of DNA Methyltransferase 1 Is a Hallmark of Melanoma, Correlating with Proliferation and Response to B-Raf and Mitogen-Activated Protein Kinase Inhibition in Melanocytic Tumors.
Am J Pathol
; 190(10): 2155-2164, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32679231